Description

According to StrategyHelix, the global surgical sealant market is expected to increase by US$ 1,511.6 million during 2022-2028, expanding at a CAGR of 8.3% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for surgical sealant. The global surgical sealant market is segmented on the basis of type of material, indication, surgical application, and region. Based on type of material, the global surgical sealant market is categorized into biological, synthetic, others. The biological segment held the largest share of the global surgical sealant market in 2021 and is anticipated to hold its share during the forecast period. On the basis of indication, the global surgical sealant market has been segmented into tissue engineering, tissue sealing and hemostasis. By surgical application, the global surgical sealant market has been segmented into cardiovascular, central nervous system, cosmetic, general surgery, ophthalmic, orthopedic, pulmonary, others. The cardiovascular segment was the largest contributor to the global surgical sealant market in 2021. Geographically, the global surgical sealant market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America is estimated to account for the largest share of the global surgical sealant market.

The global surgical sealant market is highly competitive. The prominent players operating in the global surgical sealant market include Advanced Medical Solutions Group plc (Sealantis Limited), B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., CryoLife Inc. (Artivion Inc.), Johnson & Johnson, Ocular Therapeutix Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the surgical sealant market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Type of material: biological, synthetic, others
Indication: tissue engineering, tissue sealing and hemostasis
Surgical application: cardiovascular, central nervous system, cosmetic, general surgery, ophthalmic, orthopedic, pulmonary, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global surgical sealant market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Surgical sealant market overview
Part 3. Market breakdown by type of material
– Biological
– Synthetic
– Others
Part 4. Market breakdown by indication
– Tissue engineering
– Tissue sealing and hemostasis
Part 5. Market breakdown by surgical application
– Cardiovascular
– Central nervous system
– Cosmetic
– General surgery
– Ophthalmic
– Orthopedic
– Pulmonary
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Advanced Medical Solutions Group plc (Sealantis Limited)
– B. Braun Melsungen AG
– Baxter International Inc.
– Becton, Dickinson and Co.
– Cardinal Health, Inc.
– CryoLife, Inc. (Artivion, Inc.)
– Johnson & Johnson
– Ocular Therapeutix, Inc.
About StrategyHelix
Disclaimer